TY - JOUR
T1 - A quality improvement approach in co-developing a primary healthcare package for raising awareness and managing female genital schistosomiasis in Nigeria and Liberia
AU - Oluwole, Akinola S.
AU - Bettee, Anthony K.
AU - Nganda, Motto
AU - Piotrowski, Helen
AU - Fapohunda, Victoria O.
AU - Adejobi, Josephine B.
AU - Soneye, Islamiat Y.
AU - Kafil-Emiola, Maryam A.
AU - Soyinka, Festus O.
AU - Nebe, Obiageli J.
AU - Ekpo, Uwem F.
AU - Kollie, Karsor K.
AU - Isiyaku, Sunday
AU - Thomson, Rachael
AU - Dean, Laura
AU - Ozano, Kimberley
PY - 2023/3/24
Y1 - 2023/3/24
N2 - Background:Girls and women living in endemic areas for urogenital schistosomiasis may have lifelong vulnerability to female genital schistosomiasis (FGS). For >2 decades, the importance of FGS has been increasing in sub-Saharan Africa, but without established policies for case detection and treatment. This research aimed to understand the level of FGS knowledge of frontline health workers and health professionals working in endemic areas and to identify health system needs for the effective management of FGS cases and prevention of further complications due to ongoing infections. Methods:Workshops were conducted with health workers and stakeholders using participatory methods. These workshops were part of a quality improvement approach to develop the intervention.Results:Health workers’ and system stakeholders’ knowledge regarding FGS was low. Participants identified key steps to be taken to improve the diagnosis and treatment of FGS in schistosomiasis-endemic settings, which focused mainly on awareness creation, supply of praziquantel, development of FGS syndromic management and mass administration of praziquantel to all eligible ages. The FGS intervention component varies across countries and depends on the health system structure, existing facilities, services provided and the cadre of personnel available.Conclusion:Our study found that co-developing a new service for FGS that responds to contextual variations is feasible, promotes ownership and embeds learning across health sectors, including healthcare providers, NTD policymakers and implementers, health professionals and community health workers.
AB - Background:Girls and women living in endemic areas for urogenital schistosomiasis may have lifelong vulnerability to female genital schistosomiasis (FGS). For >2 decades, the importance of FGS has been increasing in sub-Saharan Africa, but without established policies for case detection and treatment. This research aimed to understand the level of FGS knowledge of frontline health workers and health professionals working in endemic areas and to identify health system needs for the effective management of FGS cases and prevention of further complications due to ongoing infections. Methods:Workshops were conducted with health workers and stakeholders using participatory methods. These workshops were part of a quality improvement approach to develop the intervention.Results:Health workers’ and system stakeholders’ knowledge regarding FGS was low. Participants identified key steps to be taken to improve the diagnosis and treatment of FGS in schistosomiasis-endemic settings, which focused mainly on awareness creation, supply of praziquantel, development of FGS syndromic management and mass administration of praziquantel to all eligible ages. The FGS intervention component varies across countries and depends on the health system structure, existing facilities, services provided and the cadre of personnel available.Conclusion:Our study found that co-developing a new service for FGS that responds to contextual variations is feasible, promotes ownership and embeds learning across health sectors, including healthcare providers, NTD policymakers and implementers, health professionals and community health workers.
KW - female genital schistosomiasis
KW - health systems
KW - health worker training
KW - participatory research
KW - primary healthcare
KW - quality improvement
U2 - 10.1093/inthealth/ihac056
DO - 10.1093/inthealth/ihac056
M3 - Article
SN - 1876-3413
VL - 15
SP - i30-i42
JO - International Health
JF - International Health
ER -